Business Description
Getein Biotech Inc
ISIN : CNE100002RR9
Share Class Description:
SHSE:603387: Class ATotal Employee Number:
1,733Compare
Compare
Traded in other countries / regions
603387.China Index Membership
SSE Composite Index IPO Date
2017-07-17Description
Getein Biotech Inc is an in-vitro diagnostic company. It is specializing in analytical medical devices and point-of-care testing kits. Its product lines consist of cardiovascular, inflammatory, diabetes, fertility, renal, liver and specialty assays.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.38 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | 1.6 | |||||
Interest Coverage | 24.6 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 5.03 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -16.3 | |||||
3-Year EBITDA Growth Rate | -20.1 | |||||
3-Year EPS without NRI Growth Rate | -26.6 | |||||
3-Year FCF Growth Rate | -2.6 | |||||
3-Year Book Growth Rate | 3.5 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 65.08 | |||||
9-Day RSI | 59.74 | |||||
14-Day RSI | 57.04 | |||||
3-1 Month Momentum % | -21.66 | |||||
6-1 Month Momentum % | -12.3 | |||||
12-1 Month Momentum % | -12.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.21 | |||||
Quick Ratio | 2.94 | |||||
Cash Ratio | 1.88 | |||||
Days Inventory | 200.53 | |||||
Days Sales Outstanding | 122.54 | |||||
Days Payable | 200.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.7 | |||||
Dividend Payout Ratio | 0.36 | |||||
3-Year Dividend Growth Rate | -19.1 | |||||
Forward Dividend Yield % | 3.37 | |||||
5-Year Yield-on-Cost % | 2.62 | |||||
Shareholder Yield % | 4.86 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 68.26 | |||||
Operating Margin % | 24.84 | |||||
Net Margin % | 21.64 | |||||
EBITDA Margin % | 23.43 | |||||
FCF Margin % | 26.16 | |||||
OCF Margin % | 38.73 | |||||
ROE % | 8.53 | |||||
ROA % | 6.15 | |||||
ROIC % | 10.57 | |||||
3-Year ROIIC % | 829.25 | |||||
ROC (Joel Greenblatt) % | 17.79 | |||||
ROCE % | 8.75 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 19.35 | |||||
Forward PE Ratio | 8.58 | |||||
PE Ratio without NRI | 17.59 | |||||
Shiller PE Ratio | 14.59 | |||||
Price-to-Owner-Earnings | 62.68 | |||||
PS Ratio | 4.19 | |||||
PB Ratio | 1.59 | |||||
Price-to-Tangible-Book | 1.72 | |||||
Price-to-Free-Cash-Flow | 15.91 | |||||
Price-to-Operating-Cash-Flow | 10.76 | |||||
EV-to-EBIT | 14.6 | |||||
EV-to-EBITDA | 14.6 | |||||
EV-to-Revenue | 3.42 | |||||
EV-to-FCF | 13.07 | |||||
Price-to-GF-Value | 1.18 | |||||
Price-to-Projected-FCF | 1.1 | |||||
Price-to-Graham-Number | 1.16 | |||||
| Price-to-Net-Current-Asset-Value | 3.11 | |||||
| Price-to-Net-Cash | 9.27 | |||||
Earnings Yield (Greenblatt) % | 6.85 | |||||
FCF Yield % | 6.23 | |||||
Forward Rate of Return (Yacktman) % | -13.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Getein Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,075.067 | ||
| EPS (TTM) (Â¥) | 0.46 | ||
| Beta | 0.8841 | ||
| 3-Year Sharpe Ratio | -0.69 | ||
| 3-Year Sortino Ratio | -0.84 | ||
| Volatility % | 30.16 | ||
| 14-Day RSI | 57.04 | ||
| 14-Day ATR (Â¥) | 0.33677 | ||
| 20-Day SMA (Â¥) | 8.593 | ||
| 12-1 Month Momentum % | -12.5 | ||
| 52-Week Range (Â¥) | 7.37 - 11.42 | ||
| Shares Outstanding (Mil) | 507.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Getein Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Getein Biotech Inc Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.150000 Cash Dividend | 2026-06-18 | 8.12 (-1.22%) | ||
| CNY 0.090000 Cash Dividend | 2025-09-15 | 8.49 (-0.47%) | ||
| CNY 0.090000 Cash Dividend | 2025-06-17 | 8.07 (-0.98%) | ||
| CNY 0.090000 Cash Dividend | 2024-09-19 | 7.00 (-2.37%) | ||
| 1.4:1 Stock Split | 2022-06-08 | 14.01 (+0.72%) | ||
| 1.4:1 Stock Split | 2021-06-23 | 16.10 (+0.00%) | ||
| 1.4:1 Stock Split | 2019-05-21 | 13.26 (-4.01%) | ||
| 1.4:1 Stock Split | 2018-06-01 | 21.37 (-1.27%) |
Show
Entries
Getein Biotech Inc Frequently Asked Questions
What is Getein Biotech Inc(SHSE:603387)'s stock price today?
The current price of SHSE:603387 is ¥8.90. The 52 week high of SHSE:603387 is ¥11.42 and 52 week low is ¥7.37.
When is next earnings date of Getein Biotech Inc(SHSE:603387)?
The next earnings date of Getein Biotech Inc(SHSE:603387) is .
Does Getein Biotech Inc(SHSE:603387) pay dividends? If so, how much?
The Dividend Yield %  of Getein Biotech Inc(SHSE:603387) is 2.7% (As of Today), Highest Dividend Payout Ratio of Getein Biotech Inc(SHSE:603387) was 0.83. The lowest was 0.26. And the median was 0.4. The  Forward Dividend Yield % of Getein Biotech Inc(SHSE:603387) is 3.37%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Getein Biotech Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers